News

Statin users ate more, gained more weight during 1999-2010

View on the News

Statins give false reassurance

"There remains much controversy over the risks and benefits of statins for primary prevention," wrote Dr. Rita Redberg in an editor’s note. "Besides the risks of muscle aches, diabetes, and cognitive dysfunction, I have observed over the years that for many patients, statins provide a false reassurance, as people seem to believe that statins can compensate for poor dietary choices and a sedentary life."


Dr. Rita Redberg

The analysis of 1999-2010 NHANES data "documented "exactly such behavior," Dr. Redberg wrote. "[S]tatin users significantly increased their fat intake and calorie consumption, along with their BMI [body mass index], in the last decade."

The article "raises concerns of a potential moral hazard of statin use, in addition to the already known adverse effects. Focusing on cholesterol levels can be distracting from the more beneficial focus on healthy lifestyle to reduce heart disease risk."

Dr. Redberg of the department of medicine and women’s cardiovascular services at the University of California, San Francisco, is editor of JAMA Internal Medicine.


 

FROM JAMA INTERNAL MEDICINE

U.S. adults who take statins consumed 14.4% more fat and 9.6% more calories in 1999-2000 than a decade earlier, while the prevalence of statin use more than doubled during that time, investigators reported online April 24 in JAMA Internal Medicine.

But fat and calorie intake did not change significantly among statin nonusers during the study period, reported Dr. Takehiro Sugiyama of the University of California, Los Angeles, and the University of Tokyo, and her associates.

The findings raise questions about managing hyperlipidemia in an era of epidemic obesity, diabetes, and "soaring" health care costs, the researchers said.

© Jeffrey Hamilton/Thinkstock

Though the prevalence of statin use has doubled since the late 1990’s, many statin users are still consuming more fat and calories than recommended.

"We need to consider if it is an acceptable public health strategy to encourage statin use without also taking measures to decrease the likelihood that its use will be associated with increased caloric and fat intake as well as weight gain," they added. "We believe that the goal of statin treatment, as with any pharmacotherapy, should be to allow patients to decrease risks that cannot be decreased without medication, not to empower them to put butter on their steaks."

Dr. Sugiyama and her colleagues performed repeated cross-sectional analyses of NHANES (National Health and Nutrition Examination Survey) data on 27,886 U.S. adults aged 20 years and older during 1999-2010 (JAMA Intern. Med. 2014 [doi:10.1001/jamainternmed.2014.1927]).

At the start of the study period, statin users consumed 179 fewer kcal/day (2,000 vs. 2,179 kcal/day; P =.007) and 9.5 fewer grams of fat/day (71.7 vs. 81.2 g/day; P = .003) than did nonusers, "as we would expect for persons attempting to control their cholesterol level and weight," the researchers said.

But the gaps between the two groups narrowed as statin users consumed more calories and fat during the next several years. By 2009-2010, statin users consumed 9.6% more calories and 14.4% more fat than they had in 1999-2000, both statistically significant differences. In fact, statin users consumed 54 more calories and 2.7 g more/day than did nonusers. Furthermore, their body mass index increased significantly, by 1.3 kg/m2 during 1999-2010, compared with the BMI increase in nonusers of 0.5 kg/m2, the investigators reported.

Statin use "may have undermined the perceived need to follow dietary recommendations," the researchers wrote. Patients, perceiving the drastic effect of statins on LDL cholesterol levels, "may have lost the incentive" to change their diet. Physicians might have contributed to the process by shifting the focus of consultations from diet to adherence to statin therapy, the researchers added.

"Another possible mechanism is that expanded statin use occurred in people who were likely to eat more," the researcher said. "Some patients may have agreed to initiate statin therapy because they did not want to restrict their diet, whereas others who did not want to take medication may have declined the proposed pharmacotherapy in favor of following dietary recommendations."

The National Center for Global Health and Medicine in Japan, the Honjo International Scholarship Foundation in Tokyo, and the National Institutes of Health funded the study. The authors reported no conflicts of interest.

Recommended Reading

'Revolutionary' LDL lowering shown in evolocumab phase III trials
MDedge Endocrinology
'Favorable signal' for secondary coronary prevention in STABILITY
MDedge Endocrinology
VIDEO: Novel drug misses mark for MI prevention, but shows promise
MDedge Endocrinology
VIDEO: PCSK9 inhibitors placed in perspective
MDedge Endocrinology
Stress cardiac magnetic resonance feasible and prognostic in obese patients
MDedge Endocrinology
ACC/AHA cardiovascular risk equations get a thumbs-up
MDedge Endocrinology
When low HDL means ‘no sweat’
MDedge Endocrinology
Asymptomatic stenosis could cause cognitive impairment
MDedge Endocrinology
LDL particle number advantageous in managing cardiovascular risk
MDedge Endocrinology
High-normal HbA1c signals CAD risk in nondiabetic patients
MDedge Endocrinology